17/04/2014 02:56:41 Free Membership Login

Angel Biotechnology Company Financial Information

 Company name: Angel Biotech
 EPIC: ABH (delisted) Trading Currency: GBX
 Market Sector: AIM ISIN: GB00B0HZJ337
 Market Segment: AIM Share Type: DE
 WWW Address:  Description: ORD 0.1P
 Industry Sector: PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 0.05 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 1.64 3,273.62 -0.49 -0.05 - - - -

Angel Biotechnology Key Figures

(at previous day's close)
Market Cap.1.64m
Shares In Issue3,273.62m
Prev. Close0.05
PE Ratio- 
Dividend Yield-%
EPS - basic-0.05p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.07p
Return On Equity (ROE)-71.94%
Operating Margin-37.58%
PEG Factor- 
EPS Growth Rate-600.00%
Dividends PS Growth Rate-%
Net Debt0.31m
Gross Gearing33.13%
Quick Assets1.71m
Net Working Capital0.95m
Intangibles / Fixed Assets0.44%
Turnover PS0.11p
Pre-Tax Profit PS-0.04p
Retained Profit PS-0.04p
Cash PS0.02p
Net Cash PS-0.01p
Net Tangible Asset Value PS *0.06p
Net Asset Value PS0.06p
Spread- (-%) 

Angel Biotechnology Balance Sheet

LSE:ABH:Liabilities+EQLSE:ABH:Assets

Angel Biotechnology Share Price

Sorry No Data Available

Angel Biotechnology Share Price (5 years)

Angel Biotechnology Historic Returns

Sorry No Data Available

Angel Biotechnology Key Management Ratios

Angel Biotechnology Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.77 
Tobin's Q Ratio (excl. intangibles)0.77 
Dividend Yield-%
Market-to-Book Ratio0.91 
Price-to-Pre-Tax Profit PS-1.26 
Price-to-Retained Profit PS-1.26 
Price-to-Cash Flow PS-0.75 
Price-to-Sales PS0.47 
Price-to-Net Tangible Asset Value PS0.91 
Price-to-Cash PS2.82 
Net Working Capital PS0.03 
Price Pct to Working Capital PS1.73%
Earnings Yield-%
Average PE21.55 
Years in average2 
PE to PE average-%

Angel Biotechnology Financial Ratios

(Leverage Ratios)
Debt Ratio6.94%
Debt-to-Equity Ratio0.07 
Debt-to-Equity Ratio (excl. Intgbl)0.07 
Debt-to-Equity Market Value0.08 
Net Gearing11.64%
Net Gearing (excl. Intangibles)11.66%
Gross Gearing33.13%
Gross Gearing (excl. Intangibles)33.19%
Gearing Under 1 Year28.14%
Gearing Under 1 Year (excl. Intgbl)28.19%
Assets/Equity1.50 
Cash/Equity32.14 
(Liquidity Ratios)
Net Working Capital to Total Assets35.08%
Current Ratio2.25 
Quick Ratio (Acid Test)2.25 
Liquidity Ratio0.76 
Cash & Equiv/Current Assets33.99%
(Solvency Ratios)
Enterprise Value1.19m
CFO/Sales-0.63 
CFO/Attributable Profit- 
CFO/Assets-0.81 
CFO/Debt-2.44 
Total Debt/Equity Market Value0.55 
Total Debt/Sales0.26 
Total Debt/Pre-Tax Profit-0.69 
Total Debt0.89m
Total Debt/Net Current Assets0.94%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-14.59%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)
-0.49200.3456
Alpha (60-Mnth)Alpha (36-Mnth)
-0.0265-0.0830

Angel Biotechnology Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-66.95%
Return On Assets (ROA)-60.86%
Net Profit Margin-37.58%
Assets Turnover1.62 
Return On Equity (ROE)-71.94%
Return On Investment (ROI)-128.92%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-37.58%
(Asset Utilisation Multiples)
Shareholders Equity Turnover3.68 
Fixed Assets Turnover4.88 
Current Assets Turnover2.42 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales0.62 
Debtors-to-Sales24.00%
Debt Collection Period87.60Days

Angel Biotechnology Dividends

Sorry No Data Available

Angel Biotechnology Fundamentals

 31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Mar 2012 (GBP)
turnover0.95-1.48100.00%2.95100.00%3.46100.00%m
pre tax profit-1.09--0.75-51.08%0.196.56%-1.30-37.58%m
attributable profit-1.09--0.75-51.08%0.196.56%-1.30-37.58%m
retained profit-1.09--0.75-51.08%0.196.56%-1.30-37.58%m
eps - basic-0.08 0.05 0.01 -0.05 
eps - diluted-0.08 0.05 0.01 -0.05 
dividends per share- - - - 

Angel Biotechnology Balance Sheet

 31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Mar 2012 (GBP)
LSE:ABH:Liabilities+EQLSE:ABH:AssetsLSE:ABH:Liabilities+EQLSE:ABH:AssetsLSE:ABH:Liabilities+EQLSE:ABH:AssetsLSE:ABH:Liabilities+EQLSE:ABH:Assets
 31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Mar 2012 (GBP)
ASSETS
fixed assets fixed assets0.41-0.36-0.4226.53%0.9936.62%m
intangibles intangibles0.00-0.00-0.010.44%0.000.16%m
fixed investments fixed investments------%--%m
current assets - other current assets - other------%--%m
stocks stocks------%--%m
debtors debtors0.20-0.24-0.5333.93%1.1341.73%m
cash & securities cash & securities0.07-0.06-0.6139.10%0.5821.49%m
TOTAL0.68100%0.66100%1.57100%2.70100%m
LIABILITIES
creditors - short creditors - short1.54-2.25-1.4995.23%0.7628.14%m
creditors - long creditors - long0.04-----%0.134.99%m
creditors - other creditors - other------%--%m
subordinated loans subordinated loans------%--%m
insurance funds insurance funds------%--%m
TOTAL1.58-2.25-1.4995.23%0.8933.13%m
EQUITY
ord cap, reserves ord cap, reserves-0.90--1.59-0.074.77%1.8166.87%m
prefs, minorities prefs, minorities------%--%m
TOTAL-0.90--1.59-0.074.77%1.8166.87%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Angel Biotechnology Cash Flow Statement

31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Mar 2012 (GBP)
Operating CF-0.78-0.05-0.54-2.18m
Pre-Financing CF-0.88-0.05-0.65-2.67m
Retained CF0.03-0.010.55-0.03m

Angel Biotechnology Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
HB Markets plcMarket Maker(MMF)Broker/DealerHOODHOPBGB2L
Liberum Capital LimitedMarket Maker(MMF)Broker/DealerLIBCLCAPGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse abh140417 02:56